Tag: Dopamine Receptors; Schizophrenia; sLORETA; Mesolimbic

Electrophysiological Neuroimaging Using Sloreta Comparing 100 Schizophrenia Patients to 48 Patients with Major Depression

In this retrospective of electroencephalograms were to identify a surrogate biomarker for the Dopamine D2 receptors in the brain by comparing patients diagnosed with Schizophrenia taking Atypical Antipsychotics to Depressive patients medicated with Selective Serotonin Reuptake Inhibitors. To achieve this, thirty-seconds of resting EEG were spectrally transformed in sLORETA. Three-dimensional statistical non-paramentric maps (SnPM)